INTRODUCTION
The ophthalmic application of drugs is the primary route of administration for the treatment of various eye diseases, and is well-accepted by patients; however, in traditional formulations only small amounts of the administered drug 0.5 penetrate the cornea to reach the desired intraocular tissue due to corneal barriers and dilution caused by lacrimation 1 3 . Consequently, there is a need for frequent instillation of concentrated solutions to obtain the desired therapeutic effect in both the anterior and posterior hemispheres of the eye. However, the frequent administration of drugs can cause corneal damage as well as undesirable side effects resulting from the systemic absorption of drugs through the nasolacrimal duct 4, 5 . Therefore, it is very important to increase the effectiveness of drugs by enhancing their bioavailability 6 . In order to overcome these problems and increase ocular drug bioavailability, several strategies including the preparation of viscous solutions, micro/ nanoparticles and hydrogels have been developed and in-vestigated 1, 4, 7 10 . In the case of viscous solutions, numerous studies have demonstrated that they do not possess sufficient mechanical strength to resist the ocular clearance mechanism, and offer only a transient improvement in ocular residence time 11 . On the other hand, it has been reported that the penetration capability of drugs across the cornea can be significantly improved by decreasing the particle size using nanoparticles 3, 9, 12 . Implants fabricated using the biodegradable polymer PLGA poly DL-lactideco-glycolide with mean particle diameters of 50 -200 nm have been widely utilized as carriers for bioactive molecules and present a possible solution to the limitations surrounding ocular drug penetration 13 16 . It is expected that ophthalmic drug systems using nanoparticles may provide an alternative strategy for increasing ocular drug penetration 13 16 .
as well as in vivo 17 . The variety of TL functions published to date include the suppression of collagen synthesis by fibroblasts via the down-regulation of cytokine release from monocytes/macrophages 18 , the transcriptional and translational inhibition of matrix metallo-proteases in lipopolysaccharide-stimulated neutrophils 19 , and the suppression of monocyte/macrophage infiltration and associated myocardial fibrosis in the deoxycorticosterone acetate/salt hypertensive rats 20 . Because the solubility of TL in water is very low 14.5 μg/ml , it is generally dissolved with the aid of a surface-active agent; in such a solution, TL has been widely used in the ophthalmic field as RIZABEN ® eye drops 0.5 solution, and provides effective therapy for ocular inflammation. However, this preparation of TL does not provide effective therapy for uveitis or after cataract surgery because the amount of TL in the intraocular area is low. Therefore, it is possible that enhancing the transcorneal penetration of TL will increase its effectiveness against ocular inflammation as can occur in uveitis and after cataract surgery , and lead to an expansion of its therapeutic usage in the ophthalmologic field. Preservatives are essential additives in ophthalmic preparations, and the most common preservative in preparations used to treat glaucoma and ocular surface diseases is BAC, most often at a concentration of 0.01 range, 0.005 -0.02 in topical multi-dose solutions 21 . Although, the BAC is known to cause corneal stimulation, we have previously shown that this side effect can be prevented by the addition of D-mannitol to the preparation 22 . In this study, we made preparations of TL nanoparticles containing BAC and D-mannitol, and investigated their usefulness in the ophthalmologic field by evaluating corneal toxicity and permeability.
EXPERIMENTAL

Animals and reagents
Male rabbits were housed under standard conditions 12 h/d fluorescent light 07:00-19:00 , 25 room temperature , and allowed free access to a commercial diet CR-3, Clea Japan Inc., Tokyo, Japan and water. All procedures were performed in accordance with the Kinki University Faculty of Pharmacy Committee Guidelines for the Care and Use of Laboratory Animals and the Association for Research in Vision and Ophthalmology resolution on the use of animals in research. TL TL microparticles were kindly donated by Kissei Pharmaceutical Co., Ltd. Nagano, Japan . 2-Hydroxypropyl-β-cyclodextrin HPβCD, average molar substitution, 0.6; average MW, 1380 was purchased from Nihon Shokuhin Kako Co., Ltd. Tokyo, Japan . Commercially available 0.5 TL eye drops RIZABEN ® eye drops 0.5 , TL commercially eye drops were obtained from Kissei Pharmaceutical Co., Ltd., and benzalkonium chloride BAC was provided by Kanto Chemical Co., Inc. Tokyo, Japan . Mannitol D-mannitol was purchased from Wako Pure Chemical Industries, Ltd. Osaka, Japan . All other chemicals used were of the highest purity commercially available.
Preparation of ophthalmic dispersions containing TL
nanoparticles TL nanoparticles were prepared using zirconia beads and Bead Smash 12 a bead mill, Wakenyaku Co. Ltd, Kyoto, Japan . Scheme 1 shows the preparation method for ophthalmic dispersions containing TL used in this study. Zirconia beads diameter: 2 mm were added to TL microparticles solid, original TL containing BAC or mannitol, and the mixture was crushed with a Bead Smash 12 for 30 sec 1,500 rpm, 4 . The mixture was dispersed in saline with or without 5 HPβCD, and crushed with the Bead Smash 12 5,500 rpm, 60 sec, 4 using zirconia beads diameter: 0.1 mm . The compositions of the dispersions containing TL are shown in Table 1 . A 0.5 TL dispersion is equivalent to 15.3 mM TL; the pH of both ophthalmic dispersions containing TL micro-or nanoparticles was 6. The particle size was measured using a nanoparticle size analyzer SALD-7100 Shimadzu Corp., Kyoto, Japan; refractive index 1.60-0.10i .
Stability of ophthalmic dispersions containing TL
TL concentrations in the samples were determined by a High Performance Liquid Chromatography HPLC method. Ten microliters of filtrate was added to 100 μl methanol containing 0.3 μg ethyl p-hydroxybenzoate internal standard , and the mixture was filtered through a Chromatodisk 4A pore size 0.45 μm, Kurabo Industries Ltd., Osaka, Japan . The solution 10 μl was injected into an Inertsil ® ODS-3 3 μm, column size: 2.1 mm 50 mm column GL Science Co., Inc., Tokyo, Japan on a Shimadzu LC-10AD system equipped with a column oven CTO-6A Shimadzu Corp., Kyoto, Japan . The mobile phase consisted of acetonitrile/50 mM ammonium acetate 20/80 at a flow rate of 0.25 ml/min; the column temperature was 35 , and the wavelength for detection was 230 nm. Three milliliters of ophthalmic dispersions containing TL as described in Table  1 were incubated in 5 ml test tubes in the dark at 20 for 72 h, after which 50 μl of sample solution was withdrawn from 5 mm under the surface at the indicated time intervals total height of liquid, 4 cm .
Antimicrobial activity of dispersions containing TL
nanoparticles Dispersions containing TL nanoparticles TL nano as described in Table 1 were tested for antimicrobial activity against Escherichia coli E. coli, ATCC 8739 . The organism was selected based on Japanese Pharmacopoeia JP test protocols, and the minimal inhibitory concentration 
Scheme 1 Preparation Procedures of Ophthalmic Dispersions containing TL.
MIC was determined from the lowest concentration showing antimicrobial activity 23 . According to the standard methodology, the bulk dilution was split into 10 ml aliquots, which were each inoculated with between 10 5 and 10 6 colo- 
Cell culture and treatment
The immortalized human corneal epithelial cell line HCE-T developed by Araki-Sasaki et al. 24 was used in this study. HCE-T cells were cultured in Dulbecco s modified Eagle s medium/Ham s F12 GIBCO, Tokyo, Japan containing 5 v/v heat-inactivated fetal bovine serum, 0.1 mg/mL streptomycin and 1000 IU/ml penicillin GIBCO, Tokyo, Japan . For experiments, HCE-T cells 1 10 4 cells/well were seeded in 96-well microplates IWAKI, Chiba, Japan . Ophthalmic dispersions containing 0.5 TL or commercially available 0.5 TL eye drops 200 μl were added to the cell cultures one day after seeding, and the cells were stimulated for 0 -120 sec 25 . Following stimulation, culture medium containing TetraColor One SEIKAGAKU Co. Tokyo, Japan was added, the absorbance Abs at 490 nm was measured, and cell viability was calculated according to the manufacturer s instructions as represented by equation 1 Eq. 1 :
Cell viability Abs stimulation /Abs non-stimulation 100 Eq. 1
where Abs stimulation shows the Abs of samples treated with ophthalmic dispersions containing 0.5 TL or commercially available 0.5 TL eye drops. The Abs non-stimulation shows the Abs of samples treated with saline.
2.6
In vitro transcorneal penetration of ophthalmic dispersions containing TL The in vitro transcorneal penetration of ophthalmic dispersions containing 0.5 TL or commercially available 0.5 TL eye drops was examined using the method of Iwata et al. 26 Adult Japanese albino rabbits weighing 2.5 to 3.0 kg were killed by injecting a lethal dose of pentobarbital into the marginal ear vein. The eyes were removed and the corneas were carefully separated from other ocular tissues. The individual corneas were placed on a methacrylate cell designed for transcorneal penetration studies. The side of the chamber donor chamber exposed to the exterior surface of the cornea was filled with an ophthalmic dispersion containing 0.5 TL or commercially available 0.5 TL eye drops. The other side of the chamber reservoir chamber was filled with 10 mM HEPES buffer pH 7.4 containing 136.2 mM NaCl, 5.3 mM KCl, 1.0 mM K 2 HPO 4 , 1.7 mM CaCl 2 and 5.5 mM glucose. The experiments were performed at 35 for 6 h. Fifty microliter aliquots of sample solution were withdrawn from the reservoir chamber at the indicated time intervals and replaced with the same volume of buffer. The TL concentrations in the samples were determined by HPLC method described above. Corneal viability was monitored by measuring corneal thickness 0.0625 cm, average for 5 rabbits; no significant changes in thickness were observed over the 6 h period . The obtained data were analyzed according to the following equations:
Eq. 3
where J c is the TL penetration rate, K m is the cornea/preparation partition coefficient, D is the diffusion constant within the cornea, C TL is the TL content in the ophthalmic preparation, τ is the lag time, δ is thickness of the cornea 0.0625 cm, average of 5 rabbits , Q t is the total amount of TL appearing in the reservoir solution at time t, and A is the effective area of the cornea 0.78 cm 2 . J c and τ were estimated by fitting each penetration profile to Eq. 4. The penetration coefficient through the cornea, K p , is given by J c /C TL . A nonlinear least-squares computer program was employed for the calculation 25 .
2.7 Photochemical resistance of ophthalmic dispersions containing TL The 0.5 TL nano preparation as described in Table 1 and 0.5 liquid TL in dimethyl sulfoxide were tested for photodegradability under fluorescent light 400 -700 nm . The TL preparations were exposed to 58 W/m 2 for 12 h, after which the TL concentrations in 50 μl samples were determined by the HPLC method described above.
Statistical analysis
All values are presented as mean standard deviation S.D. or standard error of the mean S.E. . Unpaired Student s t-test was used to evaluate statistical differences, and multiple groups were evaluated by one-way analysis of variance followed by Dunnett s multiple comparison. P values less than 0.05 were considered significant. Figure 1 shows the particle size distribution and mean particle diameter of dispersions containing 0.5 TL as described in Table 1 . The TL microparticles were milled by the bead mill method to a mean particle size of 8.58 6.59 μm mean S.D. . Although, the mean particle size of TL was decreased by the addition of BAC, the decrease in particle size was small. On the other hand, TL nanoparticles obtained by the addition of HPβCD had a mean particle size of 34 20 nm mean S.D. . Figure 2 shows the stability of dispersions containing 0.5 TL as described in Table   1 . The TL micro preparation precipitated 4 h after preparation. The stability of TL dispersions was increased when the bead mill method was used in conjunction with BAC addition with the Milled-TL BAC preparation precipitating 36 h after preparation. On the other hand, the addition of HPβCD enhanced the stability of the TL dispersion TL nano , and precipitation was not observed until 72 h after preparation. Figure 3 shows the antimicrobial activities of TL nano preparations. The antimicrobial activity of the 0.005 BAC solution was high with no E. coli detected 2 days after treatment. The TL nano preparation also showed high antimicrobial activity approximately equal to that of the 0.005 BAC solution. Table 1 . Particle size was determined using a nanoparticle size analyzer SALD-7100 (refractive index 1.60-0.10i). A: cumulative distribution and frequency of TL microparticles (particle size 52.1 ± 23.4 μm), B: cumulative distribution and frequency of Milled-TL (particle size 8.58 ± 6.59 μm), C: cumulative distribution and frequency of Milled-TL BAC (particle size 8.76 ± 4.21 μm), D: cumulative distribution and frequency of Milled-TL BAC-Mannitol (particle size 12.5 ± 4.10 μm), E: cumulative distribution and frequency of TL nano (particle size 0.034 ± 0.020 μm). The data are presented as means ± S.D. Figure 4 shows the changes in the viability of HCE-T cells following treatment with TL commercially eye drops or TL micro or TL nano . The viability of HCE-T cells treated with TL commercially eye drops for 60 or 120 sec was approximately 68.7 or 62.2 , respectively. On the other hand, the viability of HCE-T cells treated with TL nano was higher than in the case of the TL commercially eye drops, and no differences in the viability of HCE-T cells treated with TL micro or TL nano were observed. Figure 5 shows the in vitro transcorneal penetration of TL commercially eye drops, TL micro , and TL nano through rabbit corneas, and 
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DISCUSSION
In this study, we prepared ophthalmic formulations containing TL nanoparticles, and investigated their usefulness in the ophthalmologic field by evaluating their corneal toxicity and permeability.
BAC has been used as an effective preservative and is indispensable in the preparation of eye drops. However, BAC has also been shown to be highly toxic both in vitro and in vivo due to its stimulatory effect on epithelial cell death 27, 28 . Table 1 . The data are presented as means ± S.E. of 5 independent samples. BAC is a quaternary ammonium compound that has been shown to hasten the drying of the tear film 29, 30 , worsen preexisting dry eye 31 , and affect both the cornea and conjunctiva 32 . In addition, BAC is a pro-inflammatory or proapoptotic mediator 33 because it induces oxidative stress 34 36 or significantly alters precorneal mucins 37 . Clinically, these iatrogenic effects are found most frequently in eye drops used to treat long-term pathologies and inflammation. The side effects of BAC seem to be both dose-and time-dependent, increasing with larger amounts used for longer periods. On the other hand, we previously reported that the addition of D-mannitol prevents corneal stimulation by BAC 22 , and change in chemical structure was not observed by addition of the BAC and D-mannitol 22 . Therefore, we attempted the preparation of a TL dispersion containing BAC and mannitol using the bead mill method Milled-TL BAC-Mannitol . Although, the TL particle size in Milled-TL BAC-Mannitol 12.5 4.90 μm was lower than that of TL microparticles 52.1 23.4 μm, means S.D. , the particle size was not sufficiently small to be called a nanoparticle Fig.  1 , and the stability of Milled-TL BAC-Mannitol was also low Fig.  2 . Mori et al. 38 reported that adsorption to the surface of cyclodextrin decreases the cohesion of nanoparticulate solids, and we previously reported that the addition of HPβCD is suitable for the preparation of nanoparticles using mill methods 39 . Furthermore, Jansen et al. 40 have
reported no observable irritation of the eye membrane by solutions containing HPβCD at concentrations less than 12.5 . Therefore, we used 5 HPβCD to prepare TL nanoparticle dispersions in this study. The addition of 5 HPβCD resulted in a smaller TL particle size and an increased stability of the resulting dispersions containing TL nanoparticles TL nano . The antimicrobial activity is important in ophthalmic preparations. TL nano containing 0.005 BAC showed high antimicrobial activity with an MIC equal to that of a 0.005 BAC solution Fig. 3 . These results suggest that the TL nanoparticle dispersions in this study do not affect the antimicrobial activity of BAC, and that the chemical structure shows no difference between TL microparticles and nanoparticles. Next, we evaluated the dispersions containing TL nanoparticles in terms of corneal damage and transcorneal penetration using HCE-T cells and rabbit corneas Fig. 4 and 5 . The viability of HCE-T cells treated with TL nano was higher than that of cells treated with TL commercially eye drops, and no difference in cell viability was observed between TL micro and TL nano Fig. 4 . In the in vitro transcorneal penetration experiment, no TL was detected in the reservoir chamber until 4 h after the introduction of TL micro into the donor chamber Fig. 5 ; however, the lag time for the TL commercially eye drops was 1.93 h, and the penetration rate was obviously higher than that from TL micro Table 2 . On the other hand, the penetration from TL nano was significantly higher than that from TL commercially eye drops. Since TL nano contains HPβCD, the data suggest that the higher rate of transcorneal penetration from TL nano is a result of the increased solubility of TL due to its association with HPβCD. Also, the TL penetration rate from dispersions containing 0.5 TL nanoparticles, 0.005 BAC, 0.5 mannitol and 5 HPβCD was approximately 2-fold higher than that from dispersions containing 0. 25 tion from TL nano . In addition, liquid TL is known to be highly photodegradable, while TL nanoparticles 100 -200 nm show high photochemical resistance 41 . We also investigated the photochemical resistance of 0.5 TL nano under fluorescent light 400 -700 nm . Liquid TL in dimethyl sulfoxide was found to be photodegradable when exposed to 58 W/m 2 for 12 h remaining content 67.8 4.0 vs. before photo illumination, mean S.E. n 3 ; however, a high degree of photochemical stability was observed for TL nano remaining content 98.6 2.7 vs. before photo illumination, mean S.E. n 3 . Taken together, TL nano may provide effective therapy for patients with ocular inflammation requiring the long-term application of eye drops as can occur in uveitis and after cataract surgery . Further studies are needed to elucidate the structure of the delivery system. Therefore, we are now investigating the structure of the delivery system for TL nanoparticles by scanning electron microscopy.
CONCLUSIONS
In the present study, we attempted to establish a preparation method for drug nanoparticles, and succeeded in preparing high quality dispersions containing TL nanoparticles particle size, 34 20 nm, mean S.D. . The dispersions containing TL nanoparticles were tolerated better by human corneal epithelium cells than the commercially available 0.5 TL eye drops RIZABEN ® eye drops . In addition, the state of the dispersions containing TL nanoparticles did not affect the antimicrobial activity of BAC against E. coli, and the corneal penetration of TL from dispersions containing TL nanoparticles was significantly higher than that from commercially available TL eye drops. It is possible that dispersions containing TL nanoparticles will show increased effectiveness in treating ocular inflammation, and an ocular drug delivery system using drug nanoparticles may expand their usage for therapy in the ophthalmologic field. 
